跳至主要内容
临床试验/NCT02955537
NCT02955537已完成不适用

MI-BP: mHealth to Improve Blood Pressure Control

University of Michigan4 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2018年1月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
162
试验地点
4
主要终点
Change in mean systolic blood pressure

研究概览

简要总结

This study seeks to evaluate a multicomponent mobile intervention to change multiple hypertension-related health behaviors in minorities and the underserved with uncontrolled hypertension. Half of the participants will receive a mobile intervention designed to improve physical activity, sodium intake, and medication adherence. The other half will receive usual care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Detroit-area residents
  • Hypertensive
  • Owning a compatible smartphone
  • Presenting to the Detroit Medical Center Detroit Receiving, Sinai-Grace Hospital, or selected Community Health Screening Events with, but not necessarily for, uncontrolled blood pressure (systolic blood pressure ≥ 135 mm Hg at triage and on repeat measurement using the BpTRU device).

排除标准

  • No self-reported prior history of hypertension
  • No hypertension diagnosis documented in their medical record
  • Non-English speaking
  • Presenting with an acute illness necessitating immediate medical intervention
  • Presenting with an admission to the hospital for critical reasons (as determined by the attending physician)
  • Pregnant (as determined by a dip test at screening), or self-report during trial.
  • Having the following serious comorbidities or confounders due to the fact that they may make blood pressure control difficult or necessitate frequent Emergency Department use or hospitalization:
  • Previous diagnosis of resistant hypertension (or current use of 3 or more maximally dosed antihypertensive agents without achievement of blood pressure control)
  • Steroid dependent asthma or emphysema
  • Cirrhosis or hepatic failure
  • Chronic heart failure (any stage)
  • Previous diagnosis of acute myocardial infarction, angina (stable or unstable), or known coronary artery disease
  • Previous diagnosis of cerebrovascular disease (including transient ischemic attack or stroke)
  • Known valvular heart disease
  • Stage IV or V chronic kidney disease
  • Cancer (terminal or undergoing active chemotherapeutic or radiation therapy)
  • Patients with other serious medical conditions that may affect their ability to self-monitor blood pressure (such a dementia)
  • Having a history of alcohol or drug abuse as determined by the CAGE-AID questionnaire (excluded if 2 or more)
  • Week 2 measurement of systolic blood pressure < 130 mm Hg using the BpTRU device or study-issued BP cuff.

结局指标

主要结局

Change in mean systolic blood pressure

时间窗: from baseline to 1 year

次要结局

  • Change in physical activity as measured by the International Physical Activity Questionnaire (IPAQ-SF)(from baseline to 1 year)
  • Change in sodium intake as measured by the Block Sodium Screener(from baseline to 1 year)
  • Change in medication adherence as measured by Adherence to Refills and Medications Scale (ARMS)(from baseline to 1 year)
  • Change in blood pressure control(from baseline to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lorraine Buis

Associate Professor of Family Medicine, Medical School and Associate Professor of Information, School of Information

University of Michigan

研究点 (4)

Loading locations...

相似试验